Press Release Description

Rising Adoption of Innovative Technologies Leading to Global Next-Generation Biomanufacturing Market Growth

The Global Next-Generation Biomanufacturing market is growing at an exponential rate on an account of the rising adoption of innovative technologies and methods to upsurge productivity & flexibility and to reduce manufacturing plant footing and cost. Moreover, the increasing demand for immunotherapy drugs and the growing aging population with chronic diseases such as cancer, cardiovascular and respiratory diseases. Along with the setup of biomanufacturing plants in different countries such as Singapore and growing demand for advanced biomanufacturing practices to treat the rising patient population has encouraged the development of next-generation biomanufacturing products.

According to MarkNtel Advisorsresearch report titledGlobal Next-Generation Biomanufacturing Market Analysis, 2020”, the Global Next-Generation Biomanufacturing market is anticipated to grow at a CAGR of around 25% during 2020-25. Based on the Application, Vaccine captured the majority market share in 2019 due to the growing demand for new vaccine and burgeoning therapy production methods to increase capacity, scalability, and flexibility.

“Global Next-Generation Biomanufacturing Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and growth opportunities available for Next-Generation Biomanufacturing providers across the globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.      

North America Acquired the Majority Market Share

North America acquired a significant market share in Global Next-Generation Biomanufacturing in 2019. USA dominated the North American market on an account of extensive government investment for the development next-generation biomanufacturing due to a growing number of patients with serious diseases and spur in the treatments for many orphan diseases. Moreover, considerable advancement in technology coupled with rising discovering, developing, and manufacturing of innovative human therapeutics and expansion in the number of targeted products is anticipated fuel the demand for the Global Next-Generation Biomanufacturing market in this region as stated in MarkNtel Advisors’ research report “Global Next-Generation Biomanufacturing Market Analysis, 2020”. 

According to MarkNtel Advisors, the key players with a considerable market share in the Global Next-Generation Biomanufaon Biote B.V., bbi-bech GmbH, Meissner Filtration Products Inc., Merck KGaA, Danaher Corporation, Eppendorf AG, Esco Micro Pte. Ltd., PBS Biotech Inc., Solaris Biotechnology Srl.

Market Segmentation:

  1. By Type (Downstream Biomanufacturing, Upstream Biomanufacturing)
  2. By Application (Recombinant Proteins, Hormones, Monoclonal Antibodies, Vaccines, Others)
  3. By End-User (Research Institutions, Biopharmaceutical Companies, Contract Manufacturing Organizations)
  4. By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa)
  5. By Country (US, Canada, Mexico, Brazil, Argentina, UK, Germany, France, Italy, Spain, Russia, China, Japan, South Korea, India, Australia, UAE, Saudi Arabia, South Africa),
  6. By Company (Applikon Biotechnology B.V., bbi-biotech GmbH, Meissner Filtration Products Inc., Merck KGaA, Danaher Corporation, Eppendorf AG, Esco Micro Pte. Ltd., PBS Biotech Inc., Solaris Biotechnology Srl, Thermo Fisher Scientific Inc. etc.)

Key questions answered in the study:

  1. What are the current and future trends of the Next-Generation Biomanufacturing industry?
  2. How the industry has been evolving in terms of end-user demand and application areas?
  3. How the competition has been shaping across the countries followed by their comparative factorial indexing?
  4. What are the key growth drivers and challenges for the Next-Generation Biomanufacturing industry?
  5. What is the customer orientation, purchase behavior, and expectations from the Next-Generation Biomanufacturing firms across various regions?